Dr Reddys Laboratories (RDY) EBITDA Margin Growth (5y) (2014 - 2023)
Dr Reddys Laboratories (RDY) EBITDA Margin Growth (5y) (2014 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn |
| 3 | Zoetis | 31.79 Bn | 30.11 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.58 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | Alkermes | 8.15 Bn | 7.49 Bn | 397.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 1,261.00 |
| Mar 31, 2023 | 1,919.00 |
| Dec 31, 2022 | 1,839.00 |
| Sep 30, 2022 | 68.00 |
| Mar 31, 2021 | -704.00 |
| Sep 30, 2020 | -1,185.00 |
| Jun 30, 2020 | -616.00 |
| Sep 30, 2019 | -3,581.00 |
| Mar 31, 2019 | 2,059.00 |
| Dec 31, 2018 | -813.00 |
| Sep 30, 2018 | 1,490.00 |
| Jun 30, 2018 | 1,336.00 |
| Mar 31, 2018 | 1,313.00 |
| Dec 31, 2017 | 756.00 |
| Sep 30, 2017 | -285.00 |
| Dec 31, 2016 | -222.00 |
| Sep 30, 2016 | 1,915.00 |
| Mar 31, 2016 | 628.00 |
| Dec 31, 2015 | -1,898.00 |
| Sep 30, 2015 | 3,137.00 |